Dupuytren's Disease Clinical Trial
Official title:
Retreatment of Recurrent Contractures in Joints Effectively Treated With AA4500 (Collagenase Clostridium Histolyticum [XIAFLEX®/XIAPEX®]) in an Auxilium-sponsored Phase 3 Study in the United States, Australia, and Europe
The objectives of this study are to assess the safety and efficacy of AA4500 in the retreatment of recurrent contractures in joints that were effectively treated with AA4500 in a previous Auxilium-sponsored Phase 3 study.
Open-label, Phase 4 study in subjects who are currently participating in the long-term
follow-up study (ie, AUX-CC-860) in the United States, Australia, or Europe and who have
recurrence of contracture (ie, joint contracture increases by at least 20 degrees compared
with the Day 30 value after the last injection in a Phase 3 Auxilium-sponsored study and a
palpable cord present) in a joint that was effectively treated (ie, reduction in contracture
to 5 degrees or less 30 days after the last injection) with AA4500 in a Phase 3
Auxilium-sponsored study.
Subjects who experience recurrence of contracture in one or more effectively treated joints
may be enrolled in this retreatment study after the investigator determines subject
eligibility and after informed consent has been obtained. The investigator will treat the
cord affecting the recurrent joint with up to three injections. Only one recurrent joint will
be treated in this study.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05300893 -
Effectiveness of Night Splinting After Percutaneous Needle Fasciotomy in Dupuytren's Contracture
|
N/A | |
Recruiting |
NCT04122313 -
Post-contracture Release Radiation for Dupuytren's Disease
|
||
Completed |
NCT01450397 -
MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex
|
Phase 4 | |
Completed |
NCT03180957 -
Repurposing Anti-TNF for Treating Dupuytren's Disease
|
Phase 2 | |
Completed |
NCT00575458 -
Splinting for Dupuytren's Contracture Release
|
N/A | |
Completed |
NCT00260429 -
Collagenase in the Treatment of Dupuytrens Disease
|
Phase 3 | |
Recruiting |
NCT05067764 -
Efficacy of Aponeurectomy on the 2-year Recurrence Rate of Dupuytren's Disease
|
N/A | |
Completed |
NCT02725528 -
Evaluation of Xiaflex: Trial of Effectivenss iN Dupuytren's
|
Phase 3 | |
Completed |
NCT02193828 -
Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules
|
Phase 2 | |
Completed |
NCT00954746 -
Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859
|
N/A | |
Completed |
NCT04874870 -
Effectiveness of Splinting After Collagenase Injection
|
Phase 3 | |
Recruiting |
NCT06263699 -
Goniometry and Goniometric Measurement on Standardised Images in Dupuytren's Disease
|
||
Not yet recruiting |
NCT02294890 -
Knee Stiffness in Fibrosis Diathesis
|
N/A | |
Completed |
NCT04669704 -
Effectiveness of a Tele-Rehabilitation Evidence-based Tablet App for Rehabilitation in Traumatic Bone and Soft Injuries of the Hand, Wrist and Fingers.
|
N/A | |
Recruiting |
NCT05440240 -
Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture
|
Phase 4 | |
Recruiting |
NCT06142929 -
Micronerves in Dupuytren and the Impact of Its Dissection on Recurrence
|
||
Active, not recruiting |
NCT01446432 -
Validation of Two New Questionnaires for Dupuytren's Disease
|
N/A | |
Recruiting |
NCT06281509 -
Palmaris Longus Muscle and Dupuytren
|
N/A | |
Recruiting |
NCT06321991 -
Nodular Shrinking in Dupuytren Disease
|
Phase 2 | |
Completed |
NCT01567397 -
Registry of Dupuytren's Contracture Treatment Outcomes
|
N/A |